Skip to search.
 STI Up 0.48%

Biogen Inc. (BIIB)

-NasdaqGS
276.02 Down 4.64(1.65%) 05:00 SGT
|After Hours : 276.10 Up 0.08 (0.03%) 06:20 SGT - Nasdaq Real Time Price
Prev Close:280.66
Open:280.35
Bid:276.05 x 2600
Ask:276.88 x 300
1y Target Est:340.46
Beta:0.336393
Next Earnings Date:26-Jan-17BIIB Earnings announcement
Day's Range:275.49 - 282.72
52wk Range:223.02 - 333.65
Volume:1,857,978
Avg Vol (3m):1,798,240
Market Cap:59.59B
P/E (ttm):15.61
EPS (ttm):17.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBDown 1.65%59.59B
1 0.00%N/A
PFEDown 0.98%190.91B
ABTDown 0.30%69.63B

Key Statistics

Forward P/E (1 yr):13.16
P/S (ttm):5.35
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :20.17
Quarterly EPS Est (Dec-16) :4.97
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.49

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback